Beibei Mao
Beibei Mao publishes mostly in Oncology, Organic Chemistry and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Quinazolinone synthesis and applications and Lung Cancer Treatments and Mutations.
- World rank
- #2,172,615 of 7,710,434 ranked researchers
- Rank in China
- #336,633 of 978,568
- Works
- 69
- Citations
- 1.2k
- Citations per work
- 16.7
What does Beibei Mao research?
Beibei Mao's work is mostly in Medicine (28%), Chemistry (11%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3246.8%
- Health Sciences1928.1%
- Medicine1928.1%
- Life Sciences1014.0%
- Physical Sciences811.1%
- Chemistry811.1%
- 1Oncology13% of their works
- 2Organic Chemistry11% of their works
- 3Molecular Biology10% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Neurology6% of their works
- 6Immunology4% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Quinazolinone synthesis and applications
- Lung Cancer Treatments and Mutations
- Ferroptosis and cancer prognosis
- Synthesis and Characterization of Heterocyclic Compounds
- Neurosurgical Procedures and Complications
- Trigeminal Neuralgia and Treatments
- Cancer Genomics and Diagnostics
Which keywords describe Beibei Mao's research?
The keywords of their largest research topics: Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Antimicrobial, Synthesis, Targeted Therapy, ALK Inhibitors and Cancer.
- Mutational Signatures
- Trigeminal Neuralgia
- Microvascular Decompression
- Drug Discovery
- Quinazoline
- Ferroptosis
- Cancer
- Targeted Therapy
- Antimicrobial
- Immune Checkpoint Blockade
- Tumor Microenvironment
- PD-1 and PD-L1
- Synthesis
- ALK Inhibitors
- EGFR Mutations
- Indirubin
- Cerebrospinal Fluid Leaks
- Intracranial Hypotension
- Triazines
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Tumor Microenvironment192 topics
- Immune Checkpoint Blockade131 topic
- PD-1 and PD-L1131 topic
- Antimicrobial112 topics
- Synthesis112 topics
- Targeted Therapy102 topics
- ALK Inhibitors61 topic
- Cancer61 topic
- EGFR Mutations61 topic
- Ferroptosis61 topic
- Indirubin61 topic
- Quinazoline61 topic
- Cerebrospinal Fluid Leaks51 topic
- Drug Discovery51 topic
- Intracranial Hypotension51 topic
- Microvascular Decompression51 topic
- Triazines51 topic
- Trigeminal Neuralgia51 topic
- Cancer Genomics41 topic
- Mutational Signatures41 topic
Where does Beibei Mao work?
Beibei Mao's main affiliation in the publication record is Genecast (China), China.
How many publications and citations does Beibei Mao have?
OpenAlex counts 69 works and 1,152 citations for Beibei Mao, an h-index of 19, ranking #2,172,615 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Beibei Mao
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Beibei Mao. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.